Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahler, D. A.
Right arrow Articles by Feinstein, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahler, D. A.
Right arrow Articles by Feinstein, A. R.

Chest, Vol 85, 751-758, Copyright © 1984 by American College of Chest Physicians

ARTICLES

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

DA Mahler, DH Weinberg, CK Wells and AR Feinstein

To improve the clinical measurement of dyspnea, we developed a baseline dyspnea index that rated the severity of dyspnea at a single state and a transition dyspnea index that denoted changes from that baseline. The scores in both indexes depend on ratings for three different categories: functional impairment; magnitude of task, and magnitude of effort. At the baseline state, dyspnea was rated in five grades from 0 (severe) to 4 (unimpaired) for each category. The ratings for each of the three categories were added to form a baseline focal score (range, 0 to 12). At the transition period, changes in dyspnea were rated by seven grades, ranging from -3 (major deterioration), to +3 (major improvement). The ratings for each of the three categories were added to form a transition focal score (range, -9 to +9). In 38 patients tested with respiratory disease, interobserver agreement was highly satisfactory for both indexes. The baseline focal score had the highest correlation (r = 0.60; P less than 0.001) with the 12-minute walking distance (12 MW), while significant, but lower, correlations existed for lung function. For the transition focal score, there was a significant correlation only with the 12 MW (r = 0.33; p = 0.04). These results indicate that dyspnea can receive a direct clinical rating that provides important information not disclosed by customary physiologic tests.


This article has been cited by other articles:


Home page
 ChestHome page
C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli
The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD
Chest, December 1, 2007; 132(6): 1778 - 1785.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. A. Martinez-Garcia, J.-J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano
Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis
Chest, November 1, 2007; 132(5): 1565 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. A. Mahler, L. A. Waterman, J. Ward, C. McCusker, R. ZuWallack, and J. C. Baird
Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes
Chest, October 1, 2007; 132(4): 1283 - 1290.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. D. Aaron, K. L. Vandemheen, D. Fergusson, F. Maltais, J. Bourbeau, R. Goldstein, M. Balter, D. O'Donnell, A. McIvor, S. Sharma, et al.
Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease: A Randomized Trial
Ann Intern Med, April 17, 2007; 146(8): 545 - 555.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Camiciottoli, I. Orlandi, M. Bartolucci, E. Meoni, F. Nacci, S. Diciotti, C. Barcaroli, M. L. Conforti, M. Pistolesi, M. Matucci-Cerinic, et al.
Lung CT Densitometry in Systemic Sclerosis: Correlation With Lung Function, Exercise Testing, and Quality of Life
Chest, March 1, 2007; 131(3): 672 - 681.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R G Barr, J Bourbeau, C A Camargo, and F S F Ram
Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
Thorax, October 1, 2006; 61(10): 854 - 862.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. J. Lange, N. Lechtzin, C. Davey, W. David, T. Heiman-Patterson, D. Gelinas, B. Becker, H. Mitsumoto, and the HFCWO Study Group
High-frequency chest wall oscillation in ALS: An exploratory randomized, controlled trial.
Neurology, September 26, 2006; 67(6): 991 - 997.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. E. O'Donnell, F. Sciurba, B. Celli, D. A. Mahler, K. A. Webb, C. J. Kalberg, and K. Knobil
Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD.
Chest, September 1, 2006; 130(3): 647 - 656.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. J. Berry, N. E. Adair, and W. J. Rejeski
Use of Peak Oxygen Consumption in Predicting Physical Function and Quality of Life in COPD Patients
Chest, June 1, 2006; 129(6): 1516 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. A. Mahler
Mechanisms and Measurement of Dyspnea in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2006; 3(3): 234 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. W. Jones and A. G. N. Agusti
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
Eur. Respir. J., April 1, 2006; 27(4): 822 - 832.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
V. Z. Dourado, L. C. d. O. Antunes, S. E. Tanni, S. A. R. de Paiva, C. R. Padovani, and I. Godoy
Relationship of Upper-Limb and Thoracic Muscle Strength to 6-min Walk Distance in COPD Patients
Chest, March 1, 2006; 129(3): 551 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
B. Huijnen, F. van der Horst, L. van Amelsvoort, G. Wesseling, M. Lansbergen, P. Aarts, N. Nicolson, and A. Knottnerus
Dyspnea in elderly family practice patients. Occurrence, severity, quality of life and mortality over an 8-year period
Fam. Pract., February 1, 2006; 23(1): 34 - 39.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V Brusasco, R Hodder, M Miravitlles, L Korducki, L Towse, and S Kesten
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
Thorax, January 1, 2006; 58(5): 399 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Diaz, P. Begin, M. Andresen, M. E. Prieto, C. Castillo, J. Jorquera, and C. Lisboa
Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD
Eur. Respir. J., December 1, 2005; 26(6): 1016 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K.-C. Ong, A. Earnest, and S.-J. Lu
A Multidimensional Grading System (BODE Index) as Predictor of Hospitalization for COPD
Chest, December 1, 2005; 128(6): 3810 - 3816.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
N. J. Gross
Chronic Obstructive Pulmonary Disease Outcome Measurements: What's Important? What's Useful?
Proceedings of the ATS, November 1, 2005; 2(4): 267 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
K. E. Belmonte
Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 297 - 304.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Juan, M. Ramon, J. C. Valia, J. Cortijo, E. Rubio, E. Morcillo, and P. Calverley
Palliative Treatment of Dyspnea With Epidural Methadone in Advanced Emphysema
Chest, November 1, 2005; 128(5): 3322 - 3328.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. J. Soler-Cataluna, L. Sanchez-Sanchez, M. A. Martinez-Garcia, P. R. Sanchez, E. Salcedo, and M. Navarro
Mid-Arm Muscle Area Is a Better Predictor of Mortality Than Body Mass Index in COPD
Chest, October 1, 2005; 128(4): 2108 - 2115.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. M. Parker, N. Voduc, S. D. Aaron, K. A. Webb, and D. E. O'Donnell
Physiological changes during symptom recovery from moderate exacerbations of COPD
Eur. Respir. J., September 1, 2005; 26(3): 420 - 428.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
W. Vincken
Bronchodilator treatment of stable COPD: long-acting anticholinergics
Eur. Respir. Rev., September 1, 2005; 14(94): 23 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. A. Lynch, J. D. Godwin, S. Safrin, K. M. Starko, P. Hormel, K. K. Brown, G. Raghu, T. E. King Jr., W. Z. Bradford, D. A. Schwartz, et al.
High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis: Diagnosis and Prognosis
Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 488 - 493.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
F. J. Martinez, S. Safrin, D. Weycker, K. M. Starko, W. Z. Bradford, T. E. King Jr, K. R. Flaherty, D. A. Schwartz, P. W. Noble, G. Raghu, et al.
The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis
Ann Intern Med, June 21, 2005; 142(12_Part_1): 963 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Clin RehabilHome page
F K Mutluay, H N Gurses, and S Saip
Effects of multiple sclerosis on respiratory functions
Clinical Rehabilitation, April 1, 2005; 19(4): 426 - 432.
[Abstract] [PDF]

Home page
 ChestHome page
T. Win, A. Jackson, L. Sharples, A. M. Groves, F. C. Wells, A. J. Ritchie, and C. M. Laroche
Cardiopulmonary Exercise Tests and Lung Cancer Surgical Outcome
Chest, April 1, 2005; 127(4): 1159 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Casaburi, D. Kukafka, C. B. Cooper, T. J. Witek Jr, and S. Kesten
Improvement in Exercise Tolerance With the Combination of Tiotropium and Pulmonary Rehabilitation in Patients With COPD
Chest, March 1, 2005; 127(3): 809 - 817.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. J. Gross
Tiotropium Bromide
Chest, December 1, 2004; 126(6): 1946 - 1953.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. W. Jones
Clinical Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 167 - 170.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. A. Mahler, S. Huang, M. Tabrizi, and G. M. Bell
Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD: A Pilot Study
Chest, September 1, 2004; 126(3): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. G. De Pasquale, L. F. Arnolda, I. R. Doyle, P. E. Aylward, D. P. Chew, and A. D. Bersten
Plasma Surfactant Protein-B: A Novel Biomarker in Chronic Heart Failure
Circulation, August 31, 2004; 110(9): 1091 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. A. M. Kerstjens
The GOLD Classification Has Not Advanced Understanding of COPD
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 212 - 213.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, B. Aguilaniu, B. Make, and H. Magnussen
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Eur. Respir. J., June 1, 2004; 23(6): 832 - 840.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.B. Oostenbrink, M.P.M.H. Rutten-van Molken, M.J. Al, J.A. Van Noord, and W. Vincken
One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2004; 23(2): 241 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V.M. Pinto-Plata, C. Cote, H. Cabral, J. Taylor, and B.R. Celli
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD
Eur. Respir. J., January 1, 2004; 23(1): 28 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
P M Meek
Measurement of dyspnea in chronic obstructive pulmonary disease: what is the tool telling you?
Chronic Respiratory Disease, January 1, 2004; 1(1): 29 - 37.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Leo, P. Solli, L. Spaggiari, G. Veronesi, F. de Braud, M. E. Leon, and U. Pastorino
Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
Ann. Thorac. Surg., January 1, 2004; 77(1): 260 - 265.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. P. Tashkin and C. B. Cooper
The Role of Long-Acting Bronchodilators in the Management of Stable COPD
Chest, January 1, 2004; 125(1): 249 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
A B Rao and D Gray
Breathlessness in hospitalised adult patients
Postgrad. Med. J., December 1, 2003; 79(938): 681 - 685.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. J. Schunemann, L. Griffith, R. Jaeschke, R. Goldstein, D. Stubbing, P. Austin, and G. H. Guyatt
A Comparison of the Original Chronic Respiratory Questionnaire With a Standardized Version
Chest, October 1, 2003; 124(4): 1421 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. Ruo, J. S. Rumsfeld, M. A. Hlatky, H. Liu, W. S. Browner, and M. A. Whooley
Depressive Symptoms and Health-Related Quality of Life: The Heart and Soul Study
JAMA, July 9, 2003; 290(2): 215 - 221.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. D. Aaron, K. L. Vandemheen, P. Hebert, R. Dales, I. G. Stiell, J. Ahuja, G. Dickinson, R. Brison, B. H. Rowe, J. Dreyer, et al.
Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 26, 2003; 348(26): 2618 - 2625.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Appleton, R. Adams, S. Porter, M. Peacock, and R. Ruffin
Sustained Improvements in Dyspnea and Pulmonary Function 3 to 5 Years After Lung Volume Reduction Surgery
Chest, June 1, 2003; 123(6): 1838 - 1846.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. L. Smith, F. A. Masoudi, V. Vaccarino, M. J. Radford, and H. M. Krumholz
Outcomes in heart failure patients with preserved ejection fraction: Mortality, readmission, and functional decline
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1510 - 1518.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Tashkin and S. Kesten
Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses
Chest, May 1, 2003; 123(5): 1441 - 1449.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. L. Ries, R. M. Kaplan, R. Myers, and L. M. Prewitt
Maintenance after Pulmonary Rehabilitation in Chronic Lung Disease: A Randomized Trial
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 880 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T.J. Witek Jr and D.A. Mahler
Minimal important difference of the transition dyspnoea index in a multinational clinical trial
Eur. Respir. J., February 1, 2003; 21(2): 267 - 272.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
V. Vaccarino, Z. Q. Lin, S. V. Kasl, J. A. Mattera, S. A. Roumanis, J. L. Abramson, and H. M. Krumholz
Gender differences in recovery after coronary artery bypass surgery
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 307 - 314.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. A. Sant'Anna, R. Stelmach, M. I. Zanetti Feltrin, W. J. Filho, T. Chiba, and A. Cukier
Evaluation of Health-Related Quality of Life in Low-Income Patients With COPD Receiving Long-term Oxygen Therapy
Chest, January 1, 2003; 123(1): 136 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. M. Singh, V. A. Palda, M. B. Stanbrook, and K. R. Chapman
Corticosteroid Therapy for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review
Arch Intern Med, December 9, 2002; 162(22): 2527 - 2536.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. J. Schunemann, G. H. Guyatt, L. Griffith, D. Stubbing, and R. Goldstein
A Randomized Controlled Trial To Evaluate the Effect of Informing Patients About Their Pretreatment Responses to Two Respiratory Questionnaires
Chest, November 1, 2002; 122(5): 1701 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. A. Mahler, P. Wire, D. Horstman, C.-N. Chang, J. Yates, T. Fischer, and T. Shah
Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1084 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. Olschewski, G. Simonneau, N. Galie, T. Higenbottam, R. Naeije, L. J. Rubin, S. Nikkho, R. Speich, M. M. Hoeper, J. Behr, et al.
Inhaled Iloprost for Severe Pulmonary Hypertension
N. Engl. J. Med., August 1, 2002; 347(5): 322 - 329.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. F. Donohue, J. A. van Noord, E. D. Bateman, S. J. Langley, A. Lee, T. J. Witek Jr, S. Kesten, and L. Towse
A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol*
Chest, July 1, 2002; 122(1): 47 - 55.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Aalbers, J. Ayres, V. Backer, M. Decramer, P.A. Lier, P. Magyar, J. Malolepszy, R. Ruffin, and G.W. Sybrecht
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial
Eur. Respir. J., May 1, 2002; 19(5): 936 - 943.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Weisberg, J. Wanger, J. Olson, B. Streit, C. Fogarty, T. Martin, and R. Casaburi
Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD Patients*
Chest, April 1, 2002; 121(4): 1070 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. A. Normandin, C. McCusker, M. Connors, F. Vale, D. Gerardi, and R. L. ZuWallack
An Evaluation of Two Approaches to Exercise Conditioning in Pulmonary Rehabilitation*
Chest, April 1, 2002; 121(4): 1085 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. P. de Torres, V. Pinto-Plata, E. Ingenito, P. Bagley, A. Gray, R. Berger, and B. Celli
Power of Outcome Measurements to Detect Clinically Significant Changes in Pulmonary Rehabilitation of Patients With COPD*
Chest, April 1, 2002; 121(4): 1092 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
W. Vincken, J.A. van Noord, A.P.M. Greefhorst, Th.A. Bantje, S. Kesten, L. Korducki, and P.J.G. Cornelissen
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Eur. Respir. J., February 1, 2002; 19(2): 209 - 216.
[Abstract] [Full Text] [PDF]